While the NFL world is focused on the 2025 NFL draft that begins on Thursday, the Arizona Cardinals have something else starting on Tuesday. It is the start of their offseason program. For the next ...
Kymera Therapeutics, Inc. (KYMR) just reported positive results from its phase 1 healthy volunteer study using KT-621. The purpose of this clinical candidate is to develop it as an oral STAT6 protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback